What Makes a Good Leader?

Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.  As cases of COVID-19 began spiking on the West Coast of the...

Online Exclusives

Early Results Show Moderna’s COVID-19 Vaccine is 95% Effective

Moderna shared early findings that show its experimental coronavirus vaccine was 94.5% effective at preventing COVID-19. In a study of 30,000 people, 95 developed symptomatic...

FDA Grants Emergency Use Authorization to Bamlanivimab for COVID-19

The FDA has granted emergency use authorization to bamlanivimab, an antibody treatment for COVID-19. “It’s a great day for science and medicine,” said Daniel Skovronsky,...

News

From the Blood Journals

WIB_icon

Lower Socioeconomic Status Associated With Worse Post-Transplant Survival in Children With...

According to an analysis of data from the Center for International Blood and Marrow Transplant Research (CIBMTR), children with cancer who have Medicaid insurance...

How Common Is Venous Thromboembolism in Patients Hospitalized With COVID-19?

Reports have suggested that venous thromboembolism (VTE) is a frequent complication of COVID-19 infection, and patients are at an increased thrombotic risk even with...

Multimedia

Constantine Tam: Comparing Zanubrutinib With Ibrutinib in Waldenström Macroglobulinemia

Treatment with zanubrutinib resulted in a higher combined complete response and very good partial response rate than therapy with ibrutinib in patients with Waldenström...

John Kuruvilla: Pembrolizumab in Relapsed/Refractory Classic Hodgkin Lymphoma

Treatment with pembrolizumab prolonged progression-free survival more than brentuximab vedotin, including in patients ineligible for transplant. Dr. Kuruvilla discusses results from the phase III...

Meletios Dimopoulos: Weekly SVd Improved PFS in Relapsed/Refractory Myeloma

Once weekly combination treatment with selinexor, bortezomib, and dexamethasone led to an approximately 4-month improvement in progression-free survival compared with bortezomib plus dexamethasone. Meletios...

Shaji Kumar: Comparing KRd With VRd in Newly Diagnosed Myeloma

Initial treatment with carfilzomib, lenalidomide, and dexamethasone was not associated with greater improvements in progression-free survival compared with bortezomib, lenalidomide, and dexamethasone. Shaji Kumar,...

On Location

On location

Take Note: Virtual Format Provides Access to Thousands of High-Quality Abstracts

ASH Secretary Robert Brodsky, MD, from Johns Hopkins University School of Medicine, has been involved...

When Virtual Becomes the Reality

A behind-the-scenes look at how the American Society of Hematology reworked its annual meeting for...
On location

2020 ASH Annual Meeting Preview: Conversations With Co-Chairs

Education Program Co-chairs Scientific Program Co-chairs How are speakers being asked to modify their presentations for a...
On location

Rare Conditions of Great Importance in Differential Diagnoses

Hematologists are confronted by an array of complex and somewhat obscure conditions. As a follow-up...
On location

Balancing the Yin and Yang of Autoimmunity and Immunodeficiencies

As part of this year’s Education Program, experts will lead a case-based discussion of the...
On location

Challenges With TCRs, CAR T Cells, and Other Cell Therapies

As indications for allogeneic hematopoietic cell transplantation (HCT) and adoptive cellular therapies are expanding, more...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Announces Executive Committee Election Results, New Clinical Practice Guidelines, and more

The Votes Are In! ASH Announces Executive Committee Election Results The American Society of Hematology (ASH) has announced the election of four new members to...
ASH Directions

Diversity, Equity, and Inclusion in Hematology, and more

Diversity, Equity, and Inclusion in Hematology ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and...

Sign up for our
eNewsletter!

The Society Pages

Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal, ASH Members Elected to...

Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal  U.S. Assistant Secretary for Health Adm. Brett P. Giroir, MD, recently presented American Society of Hematology...
The Society Pages

Remembering Patti Massicotte, Nobel Prizes Awarded for Discovery of Hepatitis C and CRISPR, and...

Remembering Patti Massicotte (1955 – 2020) Mary Patricia “Patti” Massicotte, MD, FRCP, died on October 1, 2020 from cancer.Dr. Massicotte was Professor and Director of Clinical...
The Society Pages

NCI Partners with Cancer Research UK, JADPRO Appoints Beth Faiman as Editor-in-Chief, and more

Fred Hutchinson Researchers Receive $3.5-Million Grant for Inherited Blood Disorder Treatment Hans-Peter Kiem, MD, PhD, and Roland Walter, MD, PhD, from the Fred Hutchinson Cancer...

What Makes a Good Leader?

Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.  As cases...

Who’s Watching the Watchdog?

With most drugs now approved through one of the FDA’s expedited-review pathways, is the agency approving drugs too quickly? In recent years, the FDA has...

Gene Therapy for Hemophilia: Progress and Setbacks

As the FDA delayed the approval of the world’s first gene therapy for hemophilia A, companies forged ahead with phase III trials to gather...